Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Queen’s University Belfast - The Future Medicines Institute (FMI) intends to procure a peptide synthesis solution comprising equipment, associated consumables, and appropriate maintenance and support arrangements to enable in house peptide synthesis capability.
The Future Medicines Institute (FMI) is focused on the identification and development of novel therapeutics and diagnostic approaches. The required capability will support experimental workflows by enabling the generation of peptide materials essential to underpin these research activities, contributing to institutional strategic objectives in advanced therapeutics.
The solution is expected to support broader academic use, enabling access across relevant research groups and maximising utilisation. This will facilitate collaborative research activity and enhance overall institutional research capability and impact.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Vapourtec Ltd | Procurement ID: PTVL-7258-HYTZ | £236,248 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately. 3 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Aug 2026 – Aug 2027 | - | 3 | Vapourtec Ltd | pending |
Weightings from the notice.